ArticleClinicoEconomics and outcomes research : CEOR2021

US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma.

Mike Dolph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.